IonQ’s Blazing Revenue Growth Collides with FTC Roadblock on $1.8B SkyWater Takeover

The quantum computing upstart has delivered numbers that would make any growth investor’s eyes water—first-quarter revenue vaulted 755% to $64.7 million, backlog surged 554% to $470 million, and annual guidance was raised to between $260 million and $270 million. Yet for all the commercial momentum, a regulatory hitch in Washington and a divisive analyst consensus are tempering the euphoria. The Federal Trade Commission’s decision to issue a “second request” on IonQ’s planned $1.8 billion acquisition of SkyWater Technology has thrown a procedural roadblock in front of a deal that shareholders overwhelmingly approved just last week.

Shareholders of SkyWater voted on May 8 to greenlight the all-cash-and-stock transaction, with roughly 32.6 million shares in favor and only about 400,000 against—an approval rate that sent IonQ’s stock surging more than 15% the following day to $56.89. Trading volume that day hit roughly 55.9 million shares, double the three-month average. But the market’s enthusiasm was tempered by news that the FTC had already requested additional documentation under the Hart-Scott-Rodino Act on April 24, automatically extending the waiting period by at least 30 days after both companies fully comply. IonQ and SkyWater said they would respond promptly, but the timeline for closing—still penciled in for the second or third quarter of 2026—remains conditional on regulatory clearance.

The industrial logic behind the acquisition is straightforward: IonQ wants to bring semiconductor manufacturing in-house. SkyWater operates foundry and packaging facilities in Minnesota, Florida, and Texas, serving defense programs and quantum computing initiatives alongside commercial clients. By controlling its own chip production, IonQ aims to shorten wafer iteration cycles and accelerate hardware development. Under the deal, SkyWater would continue as a standalone subsidiary, while its shareholders receive $15 in cash and $20 in IonQ stock per share.

Should investors sell immediately? Or is it worth buying IonQ?

The financial picture is as bright as it is costly. Commercial customers outside the U.S. government now account for 60% of IonQ’s revenue, with 35% coming from abroad across more than 30 countries—a dramatic expansion from just a handful of markets a year ago. The company expects organic growth of 100% in 2026, up from 80% last year. Yet maintaining that trajectory comes at a price: adjusted EBITDA losses are forecast between $310 million and $330 million for the full year, though IonQ sits on a war chest of $3.1 billion in cash and investments.

Wall Street is split on whether the shares are a bargain or a bubble. Jefferies analyst Kevin Garrigan, after comparing IonQ with rival Rigetti Computing, reiterated a buy recommendation while trimming his price target from $90 to $85. He pointed to a still-intact roadmap: a 256-qubit system demonstration is confirmed for the fourth quarter of 2026, with initial customer deliveries expected to begin in the second quarter of 2027. JPMorgan and Morgan Stanley are far more cautious, lifting their targets to $50 and $48.50 respectively while maintaining hold-equivalent ratings. Their concern: pure-play quantum companies lack diversified revenue streams, leaving them vulnerable to the deep pockets of tech behemoths like the Magnificent Seven, who could eventually erode any first-mover advantage. Among 12 analysts covering IonQ, nine recommend buying, three hold, and the average price target of $64.13 implies roughly 15% upside from current levels.

Despite the strong growth narrative, two clouds persist. A scathing report from short-seller Wolfpack Research published in February 2026 alleged that some of IonQ’s historical revenue came from canceled or discontinued Pentagon programs. The company has denied the claims, but they have not been fully rebutted. Meanwhile, the FTC review means the SkyWater deal—and the supply-chain control it promises—remains in regulatory limbo. Until both the antitrust process and the short-seller allegations are resolved, the valuation debate will continue to simmer, even as quarterly numbers keep climbing.